According to
The Motley Fool, CROs are a solid investment for investors because they have experienced substantial growth because of increased research and development outsourcing by the biopharmaceutical industry. They outline specific CROs to watch in the coming years. What do you think? In a tough economic environment--are CROs solid for investment?
No comments:
Post a Comment